Summary
- Current Price
- As of today, INSM price is $107.28, down -2.48% in the most recent trading session on
- Current Price All-Time High
- INSM price is currently -49.58% below its historical high of $212.75 set on
- Market Cap
- INSM current market cap is $24B, down -40.76% year-over-year
- Revenue
- INSM current annual revenue is $606.42M, up +66.73% year-over-year
- Next Earnings
- The next earnings release for INSM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Insmed Incorporated |
| Ticker | NASDAQ: INSM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | insmed.com |
| Employees | 1,271 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $107.28 | |
| Price, 1D Change | -2.48% | |
| Market Cap | $24B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.60 | |
| Revenue | $606.42M | |
| Revenue, 1Y Change | +66.73% | |
| EPS | -$6.42 | |
| EPS, 1Y Change | -15.17% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | INSMD | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | -$6.42 | |
| EPS Estimate | -$1.78 | |
| EPS Est. Change | +72.22% | |
| Revenue | $606.42M | |
| Revenue Estimate | $1.86B | |
| Revenue Est. Change | +206.01% | |
| Current Price | $107.28 | |
| Price Target | $195.00 | - |
| Price Tgt. Change | +81.78% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$5.34 | -$5.57 | -4.32% | |
| -$5.87 | -$6.42 | -9.24% | |
| -$1.78 | N/A | +72.22% | |
| $0.56 | N/A | +108.79% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $360.57M | $363.71M | +0.87% | |
| $605.46M | $606.42M | +0.16% | |
| $1.86B | N/A | +206.01% | |
| $2.98B | N/A | +390.89% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | -42.60% | |
| Price, 3Y | +331.69% | |
| Market Cap, 1Y | -40.76% | |
| Market Cap, 3Y | +562.04% | |
| Revenue, 1Y | +66.73% | |
| Revenue, 3Y | +147.16% | |
| EPS, 1Y | -15.17% | |
| EPS, 3Y | -63.92% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $107.28 | |
| SMA 200 | $124.61 | |
| SMA 50 | $111.66 | |
| EMA 200 | $120.37 | |
| EMA 50 | $108.11 | |
| MACD | -$0.69 | |
| Beta | 0.60 | |
| ATR | $5.04 | |
| 14-Day RSI | 56.72 | |
| 10-Day Volatility | 86.46% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $606.42M | |
| EPS | -$6.42 | |
| Gross Profit | $477.48M | |
| Gross Margin | 78.74% | |
| Operating Income | -$994.78M | |
| Operating Margin | -164.04% | |
| Net Income | -$1.28B | |
| Net Margin | -210.54% | |
| EBITDA | -$978.33M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 1.02 | |
| 3.83 | ||
| 3.54 | ||
| - | ||
| 4 | ||
| 5.29 |
Valuations
| Metric | Value | Date |
|---|---|---|
| PE Ratio | - | |
| 15.49 | ||
| 32.41 | ||
| -38.13 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $738.98M | |
| $1.43B | ||
| $2.26B | ||
| $1.79B | ||
| $1.53B | ||
| $468.87M | ||
| Total Debt | $755.99M | |
| $19.26M | ||
| $79.91M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $1.88B | ||
| $1.47B | ||
| $128.94M | ||
| $0.00 | ||
| $16.45M | ||
| $0.00 | ||
| $5.03M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$935.01M | ||
| -$64.58M | ||
| $954.07M | ||
| Capex | $62.56M | |
| -$997.58M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Morgan Stanley | → | |
| Wolfe Research | → | |
| HC Wainwright & Co. | → | |
| Barclays | → | |
| Roth Capital | → | |
| Truist Securities | → | |
| JP Morgan | → | |
| Wells Fargo | → | |
| Guggenheim | → | |
| Evercore ISI Group | → |
Analyst sentiment
Institutional ownership
No data
Screeners with INSM
FAQ
- What is the ticker symbol for Insmed Incorporated?
- The ticker symbol for Insmed Incorporated is NASDAQ:INSM
- Does Insmed Incorporated pay dividends?
- No, Insmed Incorporated does not pay dividends
- What sector is Insmed Incorporated in?
- Insmed Incorporated is in the Healthcare sector
- What industry is Insmed Incorporated in?
- Insmed Incorporated is in the Biotechnology industry
- What country is Insmed Incorporated based in?
- Insmed Incorporated is headquartered in United States
- When did Insmed Incorporated go public?
- Insmed Incorporated initial public offering (IPO) was on June 1, 2000
- Is Insmed Incorporated in the S&P 500?
- No, Insmed Incorporated is not included in the S&P 500 index
- Is Insmed Incorporated in the NASDAQ 100?
- No, Insmed Incorporated is not included in the NASDAQ 100 index
- Is Insmed Incorporated in the Dow Jones?
- No, Insmed Incorporated is not included in the Dow Jones index
- When was Insmed Incorporated last earnings report?
- Insmed Incorporated's most recent earnings report was on October 29, 2026
- When does Insmed Incorporated report earnings?
- The next expected earnings date for Insmed Incorporated is February 18, 2027
Data Sources & References
- INSM Official Website www.insmed.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1104506/000110450626000009/0001104506-26-000009-index.htm
- INSM Profile on Yahoo Finance finance.yahoo.com/quote/INSM
- INSM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/insm
